Zentrum fuer klinische Studien - Dr Hanusch GmbH

Vienna 1060

1 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Coronary Heart Disease (CHD), Obesity, Overweight

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed